Magnetic Resonance Imaging News and Research

RSS

Magnetic resonance imaging (MRI) is an imaging technique which physicians use for the diagnosis and treatment of medical conditions.

Playing video games may help children become laparoscopic surgeons

Playing video games for hours on end may prepare your child to become a laparoscopic surgeon one day, a new study has shown. Reorganisation of the brain's cortical network in young men with significant experience playing video games gives them an advantage not only in playing the games but also in performing other tasks requiring visuomotor skills. The findings are published in the October 2010 issue of Elsevier's Cortex.

24 Sep 2010

Many antisocial boys may have malfunctioning brains

Antisocial boys who abuse drugs, break laws, and act recklessly are not just "bad" kids. Many of these boys may have malfunctioning brains, according to a new study by researchers at the University of Colorado School of Medicine.

24 Sep 2010

Study finds certain MRI sequences as accurate methods of assessing stent stenosis

Researchers have found that magnetic resonance imaging (MRI) may be sufficient for the routine surveillance of some great vessel (primary blood vessels [e.g., aorta and vena cavae]) stents that are commonly used to treat congenital heart defects (a defect in the structure of the heart and great vessels that is present at birth) in children and young adults, according to a study in the October issue of the American Journal of Roentgenology (www.ajronline.org). MRI is a noninvasive medical test that helps physicians diagnose and treat medical conditions.

22 Sep 2010

Warning on Australian clinics offering safe alternatives to mammograms

Experts have warned that some private clinics that are offering safe alternatives to mammograms as breast cancer screening are doing more harm than good. It is seen that clinics offering services like botox, liposuction and spray tans are increasingly providing breast cancer screening that uses thermal imaging and “electrical impedance” technology. These methods are being used on women as young as 20, with claims they can detect cancer years earlier than mammograms.

20 Sep 2010

Blood test developed for non-alcoholic fatty liver disease diagnosis

Scientists at the Basque Center for Cooperative Research in Biosciences (CIC bioGUNE) and OWL Genomics Ltd. (Bilbao, Spain), in collaboration with researchers at the INSERM and University Hospitals (APHP Pitié Salpêtrière Hospital, Pierre & Marie Curie University Paris and Centre Hospitalier Universitaire Nice, University of Nice-Sophia-Antipolis, Nice, France), Vanderbilt University (Nashville, US), the University of Southern California (Los Angeles, US), Clinic Hospital and IDIBAPS (Barcelona, Spain) and the Alcalá de Henares University (Alcalá de Henares, Spain) have used metabolomics technology to develop a blood test for non-alcoholic fatty liver disease (NAFLD) diagnosis.

19 Sep 2010

Two-thirds of public hospitals are in rural areas

Two-thirds of the nation's 1,131 public hospitals were in rural areas in 2008, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.

18 Sep 2010

UCLA conference to provide information about latest developments to help enhance quality of life of seniors

While aging impacts everyday living in many ways, the latest technologies in the medical, consumer and lifestyle fields have the potential to help older adults live better for longer.

18 Sep 2010

Researchers to contribute to brain circuit mapping in Human Connectome Project

Thirty-three researchers at nine institutions will contribute to the Human Connectome Project (http://www.humanconnectome.org/consortia). Using powerful, custom-built brain scanners, a supercomputer, new brain analysis techniques and other state-of-the-art resources, they will trace the anatomical 'wires' that interconnect thousands of different regions of the human brain's gray matter.

16 Sep 2010

JAK oral medication produces lasting relief for patients with myelofibrosis: Researchers

An oral medication produces significant and lasting relief for patients with myelofibrosis, a debilitating and lethal bone marrow disorder, researchers at The University of Texas MD Anderson Cancer Center report in the Sept. 16 New England Journal of Medicine.

16 Sep 2010

Researchers find association between physical fitness and children’s brain development

Researchers have found an association between physical fitness and the brain in 9- and 10-year-old children: Those who are more fit tend to have a bigger hippocampus and perform better on a test of memory than their less-fit peers.

16 Sep 2010

NIH awards grants to map human brain's connections in high resolution

The National Institutes of Health today awarded grants totaling $40 million to map the human brain's connections in high resolution. Better understanding of such connectivity promises improved diagnosis and treatment of brain disorders.

16 Sep 2010

Researchers identify novel molecular pathway of Parkinson’s disease

A new study led by researchers at Columbia University Medical Center has identified a novel molecular pathway underlying Parkinson's disease and points to existing drugs which may be able to slow progression of the disease.

14 Sep 2010

Laser acupuncture a plausible treatment for depression

Acupuncture produces significant changes in parts of the brain that regulate emotional states and is a biologically plausible treatment for depression and other neuropsychiatric disorders, Australian researchers have shown for the first time.

13 Sep 2010

Genmab announces Phase II ofatumumab study results in RRMS patients

Genmab A/S announced today encouraging results from an ofatumumab Phase II safety and pharmacokinetics study in patients with relapsing-remitting multiple sclerosis (RRMS).

13 Sep 2010

Studying the same information several times under different contexts results in better memory

People are more likely to remember specific information such as faces or words if the pattern of activity in their brain is similar each time they study that information, according to new research from a University of Texas at Austin psychologist and his colleagues.

10 Sep 2010

GBCAs carry new warnings on their labels about risk of NSF: FDA

The U.S. Food and Drug Administration is requiring that gadolinium-based contrast agents (GBCAs) carry new warnings on their labels about the risk of a rare and potentially fatal condition known as nephrogenic systemic fibrosis, if the drug is administered to certain patients with kidney disease.

10 Sep 2010

UC Denver researcher awarded NIH grant to study PAH

A disease that has no cure in young children and adults is getting closer attention, thanks to a University of Colorado Denver Bioengineering assistant professor and a five year National Heart Lung and Blood Institute/National Institutes of Health grant. Kendall Hunter, PhD, will perform research to improve the diagnosis and prognosis of pulmonary arterial hypertension in children and adults with approximately $700,000 over a five-year period.

10 Sep 2010

Positive results from YM BioSciences' CYT997 Phase I study for vascular disruption in tumors

YM BioSciences Inc., today announced the publication of Phase I results demonstrating that CYT997, a novel vascular disrupting agent (VDA), was well tolerated at doses that were associated with pharmacodynamic evidence of vascular disruption in tumors. The article entitled "Phase I trial of CYT997, a novel cytotoxic and vascular-disrupting agent," was published in the premier cancer journal, the British Journal of Cancer.

8 Sep 2010

Methylphenidate facilitates recovery from drug addiction

A brain-scanning study at the U.S. Department of Energy's (DOE) Brookhaven National Laboratory, conducted with collaborators from Stony Brook University, reveals that an oral dose of methylphenidate, commonly known as Ritalin, improves impaired brain function and enhances cognitive performance in people who are addicted to cocaine.

7 Sep 2010

VirtualScopics enters molecular imaging collaboration with ABX-CRO

VirtualScopics, Inc., a leading provider of quantitative imaging for clinical trials, today announced it has entered into a scientific collaboration, specific to molecular imaging, with ABX-CRO, a Dresden, Germany based full-service contract research organization. The collaboration joins two of the scientific pioneers in the use of advanced imaging for the clinical study of drugs and medical devices.

7 Sep 2010